BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Díaz-Franulic I, Caceres-Molina J, Sepulveda RV, Gonzalez-Nilo F, Latorre R. Structure-Driven Pharmacology of Transient Receptor Potential Channel Vanilloid 1. Mol Pharmacol 2016;90:300-8. [PMID: 27335334 DOI: 10.1124/mol.116.104430] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Saha S, Mohanta S, Das R, Dalai R, Divyanshi, Tiwari N, Tiwari A, Kumar A, Goswami C. Ratio of Hydrophobic-Hydrophilic and Positive-Negative Residues at Lipid-Water-Interface Influences Surface Expression and Channel Gating of TRPV1. J Membr Biol 2022;255:319-39. [PMID: 35608627 DOI: 10.1007/s00232-022-00243-z] [Reference Citation Analysis]
2 Hwang S, Jo Y, Cohen CF, Kim Y, Berta T, Park C. Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development. IJMS 2022;23:5772. [DOI: 10.3390/ijms23105772] [Reference Citation Analysis]
3 Qin L, Li J. Nerve growth factor in muscle afferent neurons of peripheral artery disease and autonomic function. Neural Regen Res 2021;16:694-9. [PMID: 33063730 DOI: 10.4103/1673-5374.293132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Heblinski M, Santiago M, Fletcher C, Stuart J, Connor M, McGregor IS, Arnold JC. Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels. Cannabis Cannabinoid Res 2020;5:305-17. [PMID: 33376801 DOI: 10.1089/can.2019.0099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
5 Jansen C, Shimoda LMN, Kawakami JK, Ang L, Bacani AJ, Baker JD, Badowski C, Speck M, Stokes AJ, Small-Howard AL, Turner H. Myrcene and terpene regulation of TRPV1. Channels (Austin) 2019;13:344-66. [PMID: 31446830 DOI: 10.1080/19336950.2019.1654347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
6 Damann N, Bahrenberg G, Stockhausen H, Habermann CJ, Lesch B, Frank-Foltyn R, Lee J, Ann J, Christoph T. In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523. Eur J Pharmacol 2020;871:172934. [PMID: 31954706 DOI: 10.1016/j.ejphar.2020.172934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Patrone LGA, Duarte JB, Bícego KC, Steiner AA, Romanovsky AA, Gargaglioni LH. TRPV1 Inhibits the Ventilatory Response to Hypoxia in Adult Rats, but Not the CO₂-Drive to Breathe. Pharmaceuticals (Basel) 2019;12:E19. [PMID: 30682830 DOI: 10.3390/ph12010019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhang X, Hu M, Yang Y, Xu H. Organellar TRP channels. Nat Struct Mol Biol 2018;25:1009-18. [PMID: 30374082 DOI: 10.1038/s41594-018-0148-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
9 Hu F, Liu HC, Su DQ, Chen HJ, Chan SO, Wang Y, Wang J. Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron. FASEB J 2019;33:668-82. [PMID: 30024789 DOI: 10.1096/fj.201800382RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Garami A, Pakai E, McDonald HA, Reilly RM, Gomtsyan A, Corrigan JJ, Pinter E, Zhu DXD, Lehto SG, Gavva NR, Kym PR, Romanovsky AA. TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds' pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development. Acta Physiol (Oxf) 2018;223:e13038. [PMID: 29352512 DOI: 10.1111/apha.13038] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
11 Bishnoi M, Khare P, Brown L, Panchal SK. Transient receptor potential (TRP) channels: a metabolic TR(i)P to obesity prevention and therapy. Obes Rev 2018;19:1269-92. [PMID: 29797770 DOI: 10.1111/obr.12703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
12 Geron M, Kumar R, Matzner H, Lahiani A, Gincberg G, Cohen G, Lazarovici P, Priel A. Protein toxins of the Echis coloratus viper venom directly activate TRPV1. Biochim Biophys Acta Gen Subj 2017;1861:615-23. [PMID: 28063984 DOI: 10.1016/j.bbagen.2017.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
13 Carnevale V, Rohacs T. TRPV1: A Target for Rational Drug Design. Pharmaceuticals (Basel) 2016;9:E52. [PMID: 27563913 DOI: 10.3390/ph9030052] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
14 Elgoyhen AB, Barajas-López C. A Latin American Perspective on Ion Channels. Mol Pharmacol 2016;90:286-7. [PMID: 27535998 DOI: 10.1124/mol.116.105510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]